FDA Awards Priority Review Voucher to BioMarin Pharmaceutical for Rare Pediatric Disease Product VOXZOGO

Summary

The FDA has issued a priority review voucher to BioMarin Pharmaceutical, Inc. for its rare pediatric disease product VOXZOGO, following a review of the product's eligibility under the Federal Food, Drug, and Cosmetic Act.